Published in Hematology Week, May 26th, 2008
SFBR President John Kerr, who first envisioned the concept, said the new company, Evestra Inc., is receiving all of the assets, personnel, and scientific know-how of the Foundation's Organic Chemistry Department, an internationally recognized research group in steroid chemistry, together with start-up funding from SFBR. In addition to funding provided by SFBR, which will initially be the majority shareholder of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hematology Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.